Skip to main content
. 2012 Feb 15;3:RRN1291. Originally published 2011 Dec 15. [Version 2] doi: 10.1371/currents.RRN1291
Transporter Incubation time (min) Probe substrate (concentration) Reference inhibitor
(concentration)
human OATP2B1 15 E3S (1 μM) Fluvastatin (10 μM)
human OAT3 5 E3S (0.3 µM) Probenecid (500 µM)
human OCT1 10 TEA (3.6 μM) Verapamil (100 μM)
human OCT2 10 Metformin (2 µM) Verapamil (100 µM)
human PEPT1 10 Gly-Sar (1.8 μM) Tyr-Phe (200 μM)
human PEPT2 10 Gly-Sar (1.8 μM) Cefadroxil (200 μM)